Home
Resources
Publications
The Effects of cytosporone-B, a Novel Antifibrotic Agent, on Vocal Fold Fibroblasts

The Effects of cytosporone-B, a Novel Antifibrotic Agent, on Vocal Fold Fibroblasts

Nao Hiwatashi, Shigeyuki Mukudai, Renjie Bing, Ryan C Branski

Laryngoscope. 2018 Dec;128(12):E425-E428.

PMID: 30325029

Abstract:

Objectives/hypothesis:
Our laboratory recently described NR4A1 as an endogenous inhibitor of TGF-β-induced vocal fold (VF) fibrosis. Our prior report described the temporal expression of NR4A1 during VF healing in vivo and the effects of NR4A1 knockdown on fibroplastic cell activities in vitro. Based on these findings, we hypothesized that cytosporone-B (Csn-B), an NR4A1 agonist, may hold significant therapeutic potential.
Study design:
In vitro.
Methods:
Human VF fibroblasts were exposed to TGF-β1+/-Csn-B. Expression of genes related to fibrosis were quantified. In addition, contraction was assayed as a surrogate for the fibrotic phenotype in our cell line.
Results:
TGF-B1 stimulated COL1A1 and ACTA2, as expected. Csn-B significantly downregulated TGF-β1-mediated upregulation of these genes (P = .009, P = .03, respectively). Csn-B had no effect on genes related to TGF-β/Smad signaling. Csn-B also decreased the TGF-β1-mediated contractile phenotype in our cells (P = .004).
Conclusions:
NR4A1 is an endogenous inhibitor of fibrosis in the vocal folds and Csn-B, as an NR4A1 agonist, may evolve as an ideal, therapeutic candidate for this challenging condition.
Level of evidence:
NA Laryngoscope, 128:E425-E428, 2018.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP321661625	Cytosporone B		321661-62-5	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: